中 / EN

BCIwiki — Brain-computer interface news, research and industry database

Latest

June 2026
06-17 · Neuracle China Policy & Regulation Regulatory Approval

Neuracle Registers UDI for K1014-35 Implantable EEG Electrode Kit

Neuracle Medical Technology (Shanghai) Co., Ltd. registered the K1014-35 Implantable EEG Electrode Kit in the NMPA Medical Device Unique Identification database. Its registration certificate number is 国械注准20263120536. The company's description lists a cortical electrode, a blank electrode, and associated tools and fixation components. It describes the kit as both a product with its own registration certificate and a component of an implantable brain-computer interface hand motor function compensation system. The notes also list an EEG transceiver, a pneumatic glove device, and software within that system. The kit's UDI entry alone does not confirm the complete system's registration status or clinical performance.
Why it matters The entry describes the kit as both a separately registered product and a system component. Its registration information should be distinguished from that of the complete system rather than treated as interchangeable.
View details →
06-17 · Neuracle China Policy & Regulation Regulatory Approval

Neuracle Registers UDI for NEO-M Hand Motor Function Compensation System

Neuracle registered the NEO-M Implantable Brain-Computer Interface Hand Motor Function Compensation System in the NMPA Medical Device Unique Identification database. Its registration certificate number is 国械注准20263120537. According to the company's description, the system includes a BCI implant, an implantable EEG electrode kit, a disposable surgical tool kit, an EEG signal transceiver, a pneumatic glove device, and EEG decoding, medical testing, and clinical management software. All three software products have release version 1.0. The entry identifies the product and its components; UDI registration itself does not validate clinical efficacy or safety.
Why it matters The description covers implantable components, external equipment, and software rather than an electrode or implant alone. The model, UDI, and registration certificate number identify the product; its name does not establish its scope of use.
View details →
06-15 · General Office of the Anhui Provincial People's Government China Policy & Regulation Industrial Planning

Anhui Splits BCI Work Across Three Cities

The General Office of China's Anhui Provincial People's Government issued the Action Plan for Accelerating Brain-Computer Interface Technology and Industry Development in Anhui (2026-2030) on June 15, 2026, document number Wan Zheng Ban Mi [2026] No. 24. Its spatial layout assigns Hefei the role of innovation origination and talent attraction, Bengbu the fabrication and validation of key components on the strength of its smart sensor industry plus a new Longhu Laboratory, and Wuhu clinical translation through a national regional medical centre and a brain science institute at Wannan Medical College. The first main task backs the University of Science and Technology of China in leading a research institute with Chinese Academy of Sciences partners. Targets fall in 2028 rather than 2027, covering at least ten application scenarios, three approved invasive clinical trials, five systems and three backbone firms.
Why it matters Anhui pushed its near-term milestone to 2028, a year later than most provinces, and phrased every target as a floor, making it the most conservative provincial plan. Yet its three-city layout assigns distinct roles rather than merely naming places, and the clinical trial target is explicitly restricted to invasive systems, which raises its substance above the modest wording.
View details →
06-13 · Xiangya Hospital, Central South University China Clinical Implantation & Procedure

Xiangya IMIE Retina Trial Restores 0.1 Vision

In Xiangya Hospital's invasive IMIE smart retina trial, a 61-year-old fully blind patient reportedly reached 0.03 stable and 0.1 best visual acuity, walking indoors unaided.
Why it matters China's second publicly disclosed visual BCI clinical case, with quantified 0.03-0.1 acuity outcomes that corroborate the Zhejiang implant and show homegrown vision restoration entering multi-site clinical validation
View details →
06-13 · Neuroelectrics United States Policy & Regulation Regulatory Approval

FDA Clears Neuroelectrics Enobio Dx EEG Systems

The FDA cleared Neuroelectrics Barcelona's Enobio Dx line, in 8-, 20- and 32-channel models, on June 13, 2026, finding it substantially equivalent under submission number K261604 through the special 510(k) pathway. The agency classifies it as a Full-Montage Standard Electroencephalograph, a Class II device under regulation 882.1400, with neurology as the assigned review panel. Neuroelectrics is known in neuromodulation and BCI research for noninvasive EEG acquisition and transcranial electrical stimulation hardware.
Why it matters Research-grade EEG hardware only reaches patients once a cleared clinical version exists, and this entry dates that version for a headset already familiar from neuromodulation and BCI labs.
View details →
06-12 United States Policy & Regulation Regulatory Approval

FDA Clears VoxNeuro Cognitive EEG Software

The FDA cleared VoxNeuro's Cognitive Function Neuroimaging (cfNI) Software, version 1.0.0, on June 12, 2026, finding it substantially equivalent under submission number K253015 through the traditional 510(k) pathway. The agency classifies it as Normalizing Quantitative Electroencephalograph Software, a Class II device under regulation 882.1400, with neurology as the assigned review panel. Normalizing quantitative EEG software compares an individual's EEG metrics against a reference population database before reporting, supporting objective assessment of cognitive function.
Why it matters Normative-database qEEG puts the weight of the claim on the reference population rather than on the algorithm, so who is in that database, and whether the patient resembles them, becomes the practical limit on what a cognitive score means.
View details →
06-12 Browse BCIwiki entries related to Germany: research, clinical progress and industry news, with original sources and related organizations. Papers Foundations & Methods

Hybrid micro-ECoG for multi-scale neural recording

Published in Cell Reports Methods on June 12, 2026, the study presents high-density micro-electrocorticography arrays that integrate silicone elastomers (optical transparency, repeated penetration with intracortical arrays) and polyimide films (fine photolithographic feature definition) for multi-scale studies of brain activity. The combination facilitates high-throughput functional mapping to identify targets and insertion of intracortical arrays for dense local sampling. The authors demonstrated functional mapping in rats, cats and marmosets, guiding multi-area laminar recordings, and demonstrated local and feedforward optogenetic stimulation to investigate cortico-cortical interactions.
Why it matters A hybrid micro-ECoG array combining transparent flexible substrates with fine lithographic features, enabling functional-mapping-guided multi-area laminar recordings, a methodological advance for neural interface devices.
View details →
06-12 · NeuroXess China Industry News Progress & Expansion

NeuroXess Says Two Paralyzed Patients Played Brain-Controlled Chess 800 km Apart

NeuroXess said two people with high-level paralysis played chess against each other across about 800 kilometers, between Shanghai and Nanchang in eastern China, using its "Triple-Full" (三全) brain-computer interface: one selected and placed pieces on a virtual board by thought, with the commands relayed in real time to a robot stand-in that moved the pieces at the other end, where the second participant gripped physical pieces through a brain-controlled exoskeleton glove. The company said the first participant was implanted at Huashan Hospital, Fudan University, in October 2025, moved a cursor by thought on the fifth day after surgery and reached 5.2 bits per second after 17 days of training, while the second was implanted at the First Affiliated Hospital of Nanchang University in December 2025 and was eating, drinking and writing with a brain-controlled exoskeleton one month after surgery. The outcomes come from the vendor's own account and have not been validated in peer-reviewed publication.
Why it matters Reported as China's first remote brain-controlled interaction between two implanted patients, the demonstration moves NeuroXess's pitch from single-patient capability to networked, multi-site use, though every performance figure here comes from the company rather than from a trial report.
View details →
06-11 · Neuracle China Funding Public Markets

China's Neuracle Files for Shanghai IPO, Seeking RMB 2.5 Billion

The Shanghai Stock Exchange accepted an IPO application from Neuracle, which is seeking RMB 2.5 billion for BCI product development, industrialization and working capital. The filing shows an established non-invasive neurophysiology equipment business alongside invasive products that still require clinical, regulatory and commercialization spending. Acceptance starts the review process and is not approval to list.
Why it matters The prospectus puts Neuracle's revenue, losses, product pipeline and capacity plans into one regulated disclosure, creating a rare public benchmark for China's BCI sector.
View details →
06-10 · Utrecht University Netherlands Papers Communication & Language

Utrecht Team Finds Well-Placed 32-Electrode ECoG Grid Matches Larger Arrays for Speech BCI

A team led by the UMC Utrecht Brain Center in the Netherlands analyzed 8 participants with high-density electrocorticography (ECoG) grids of 64 to 128 electrodes and found that a well-positioned 32-electrode grid classified 12 Dutch words with 76 ± 16% accuracy, comparable to 75 ± 17% for the larger grids. The best placement was vertical and centered on the central sulcus. Speech brain-computer interfaces aim to restore communication to people paralyzed and unable to speak, but larger grids carry higher surgical risk. The participants were not paralyzed and testing was limited to a fixed word set.
Why it matters How much of the skull must be opened is a major concern for implanted speech BCIs, and showing that 32 electrodes covering 325 to 561 square millimeters lose no accuracy when placed correctly supports smaller, lower-power fully implantable devices. The conclusion still needs confirmation in the target population.
View details →

© 2026 BCIwiki.com Digest Topics Tips Subscribe Revisions About